The crude incidence rate of S. aureus bacteremia was lower in the dabigatran group compared with the factor Xa-inhibitor group {22.8 [95% confidence interval (CI), 19.7–26.3] and 33.8 (95% CI, 30.5–37.6) events per 10,000 person-years, respectively}. The gene discussed is F10; the disease is bacterial infectious disease with sepsis.